Volume 12

1

Are COX-2 inhibiotrs safe for anyone

Year:
2006
Language:
english
File:
PDF, 74 KB
english, 2006
3

Crohn's disease: Is it becoming more common?

Year:
2006
Language:
english
File:
PDF, 72 KB
english, 2006
4

Another tool in the epidemiologist's toolbox

Year:
2006
Language:
english
File:
PDF, 64 KB
english, 2006
12

Risk factors for colorectal cancer in Crohn's colitis: A case-control study

Year:
2006
Language:
english
File:
PDF, 116 KB
english, 2006
48

To be or not to be: Infliximab during pregnancy?

Year:
2006
Language:
english
File:
PDF, 73 KB
english, 2006
49

From SNPs to haplotypes: Unraveling the role of MDR1 in IBD

Year:
2006
Language:
english
File:
PDF, 80 KB
english, 2006
59

Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

Year:
2006
Language:
english
File:
PDF, 338 KB
english, 2006
60

Developments in the apheresis procedure for the treatment of inflammatory bowel disease

Year:
2006
Language:
english
File:
PDF, 257 KB
english, 2006
61

Preliminary data on the use of apheresis in inflammatory bowel disease

Year:
2006
Language:
english
File:
PDF, 210 KB
english, 2006
62

Introduction

Year:
2006
Language:
english
File:
PDF, 54 KB
english, 2006
68

21st century therapy for the inflammatory bowel diseases

Year:
2006
Language:
english
File:
PDF, 50 KB
english, 2006
70

Revolution and evolution: 30 years of ileoanal pouch surgery

Year:
2006
Language:
english
File:
PDF, 240 KB
english, 2006
80

As if mothers don't have enough to worry about…

Year:
2006
Language:
english
File:
PDF, 72 KB
english, 2006
82

Role of the IBD5 susceptibility locus in the inflammatory bowel diseases

Year:
2006
Language:
english
File:
PDF, 272 KB
english, 2006
83

CDP870 in Crohn's disease: Reconsidering Endpoints

Year:
2006
Language:
english
File:
PDF, 49 KB
english, 2006
87

Risky business? Crohn's disease-related mortality

Year:
2006
Language:
english
File:
PDF, 70 KB
english, 2006
94

Predicting the Crohn's disease activity index from the harvey-bradshaw index

Year:
2006
Language:
english
File:
PDF, 250 KB
english, 2006
95

Rifaximin for active ulcerative colitis

Year:
2006
Language:
english
File:
PDF, 58 KB
english, 2006
97

Outcomes of placebo therapy in inflammatory bowel disease

Year:
2006
Language:
english
File:
PDF, 96 KB
english, 2006
99

Successful infliximab therapy for oral Crohn's disease

Year:
2006
Language:
english
File:
PDF, 64 KB
english, 2006
114

FOSter your intestinal flora: Prebiotics for Crohn's disease

Year:
2006
Language:
english
File:
PDF, 75 KB
english, 2006
116

Use of antibiotics in the treatment of inflammatory bowel disease

Year:
2006
Language:
english
File:
PDF, 433 KB
english, 2006
117

A role for STAT5 in steroid-resistant UC?

Year:
2006
Language:
english
File:
PDF, 69 KB
english, 2006
118

Functional consequences of NOD2 (CARD15) mutations

Year:
2006
Language:
english
File:
PDF, 310 KB
english, 2006
126

Mycobacteria in Crohn's disease: A persistent hypothesis

Year:
2006
Language:
english
File:
PDF, 147 KB
english, 2006
141

Vicious circles in inflammatory bowel disease

Year:
2006
Language:
english
File:
PDF, 240 KB
english, 2006
146

Polypoid dysplasia in inflammatory bowel disease: Removing the bumps in the road

Year:
2006
Language:
english
File:
PDF, 71 KB
english, 2006
157

Onset of Crohn's disease after Helicobacter pylori eradication

Year:
2006
Language:
english
File:
PDF, 86 KB
english, 2006
168

Psychotherapy with chronic inflammatory bowel disease patients: A Review

Year:
2006
Language:
english
File:
PDF, 141 KB
english, 2006
174

A new wiggle on worms

Year:
2006
Language:
english
File:
PDF, 82 KB
english, 2006
175

Crohn's disease: The cost of comfortable inaction

Year:
2006
Language:
english
File:
PDF, 79 KB
english, 2006
178

Why good pouches go bad

Year:
2006
Language:
english
File:
PDF, 80 KB
english, 2006
179

Autoimmune Disease, Allergic Disease, and Microbial Stress

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
181

Tissue Response in Inflammatory Bowel Disease

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
182

Epithelial Response

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
183

Overview of Signal Transduction Pathways

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
184

GM-CSF

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
185

Risk and Mechanisms of Malignancy in IBD

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
186

Late-Breaking News

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
195

The New Epidemiology of IBD

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
196

Complex Genetic Diseases

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
197

The Genetics of IBD

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
198

Infliximab, Adalimumab and Certolizumab

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
200

Organizing Board

Year:
2006
Language:
english
File:
PDF, 61 KB
english, 2006
201

The Challenging Role of Biotherapy in IBD

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
202

Stem Cell Therapy of IBD

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
203

Therapeutic Targeting of Specific Populations (Pharmacogenetics)

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
206

6-thio-GTP Derivatives

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
207

Living with the Flora in IBD

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
209

Matrix and Mesenchymal Remodeling

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
210

Immunogenicity

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
214

The Vagus Nerve

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
220

Placebo Response in the Therapy of Crohn's Disease

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
221

Genetics Defects and Chronic Inflammation

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
222

Infliximab, Adalimumab and Certolizumab

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
225

Recurrent Disease After Resection for Crohn's Disease

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
226

Role of Toll-like Receptors in Commensal Dependent Colitis

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
227

Dentritic Cell Subspecifications in Mucosal Innate and Adaptive Immune Defenses

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
228

The Smad System

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
229

Directions for Basic Science

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
235

The Enteric Flora in IBD

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
236

Animal Models of Experimental IBD

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
237

The Immune Response in IBD

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
238

Pouch Inflammation and Neoplasia After Proctocolectomy for Ulcerative Colitis

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
239

Bacterial Flora

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
240

Role of the mTOR Signaling Pathway in Disease

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
241

Novel Therapies Create New Morbidity

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
247

Antibiotics, Probiotics, Prebiotics, Fish Oil and Micronutrients (Past)

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
248

Update on Current Genetic Associations in IBD

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
252

Implications of Genetic Heterogeneity in Inflammatory Bowel Disease

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
253

Promises of Anticytokine Therapy

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
257

Antibiotics, Probiotics, Prebiotics, Fish Oil and Micronutrients (Present)

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
258

Programme

Year:
2006
Language:
english
File:
PDF, 54 KB
english, 2006
259

NOD Proteins and Bacterial Detection

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
260

Control of Intestinal Inflammation by Regulatory T Cells

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
261

PPARγ

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
263

Global Environmental Changes and Immune Diseases

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
264

Infliximab, Adalimumab and Certolizumab

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
265

Antibiotics, Probiotics, Prebiotics, Fish Oil and Micronutrients (Future)

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
266

Presentation of Meeting

Year:
2006
Language:
english
File:
PDF, 57 KB
english, 2006
269

TGF-β-Induced CD4+FoxP3+ Cells Prevent TH1 Colitis

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
270

The Hygiene Hypothesis and the Aberrant Immune Response

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
272

Faculty

Year:
2006
Language:
english
File:
PDF, 61 KB
english, 2006
273

Signal Transduction in Chronic Inflammation

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006
278

Host Factors that Shape the Enteric Flora

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
279

The Ever-Expanding Immunological Universe

Year:
2006
Language:
english
File:
PDF, 271 KB
english, 2006
282

IL-23 and Not IL-12 Is Essential for the Development of IBD

Year:
2006
Language:
english
File:
PDF, 509 KB
english, 2006